Oncolytic virotherapy approved in Armenia

Armenian Regulator of supervision of drugs and therapeutic agents approved Latvian oncolytic virotherapy medicine for the treatment of cancer. Thus developed in Latvia unique medicine, which represents a whole branch of oncology – cancer virotherapy, is now available in yet another country.

Contacts for Media Inquiries

Rigvir Group
Address: 9-7 Teatra street, LV–1050, Riga, Latvia
Phone: +371 67 229 599
E-mail: pr@rigvir.com